Erysipelothrix rhusiopathiae is a Gram-positive bacterium that in humans causes skin infections, such as erysipeloid, as a result of direct contact with contaminated animals or their waste or products. We present the first reported case of tenosynovitis of a finger in a 30-year-old woman.
Introduction
Erysipelothrix rhusiopathiae is a Gram-positive bacterium that is mainly responsible for skin infection, mostly erysipeloid, in humans. The infection derives from direct contact with infected animals, usually domestic swine, and their products or wastes. We report a rare case of a 30-year-old woman with tenosynovitis of her right middle finger.
Case presentation
A 30-year-old Nigerian woman was admitted to our department with a medical history of swollen and painful middle finger of her right hand, which had progressively worsened over the last 3 days. No fever other constitutional symptoms were detected. She reported a recent penetrating trauma by a fish bone. No systemic diseases were documented.
Physical examination revealed edema, pain at rest, warmth and a reddish middle finger with extension to the volar and dorsal area of her hand. Skin decolourisation was not diagnostic for erysipeloid at that time. Although the range of motion of the interphalangeal and metacarpophalangeal joints was completely restricted, no vascular impairment was documented. Her peripheral white blood cell count was 13 300/μL (71% neutrophils, 17.8% lymphocytes, 10.1% monocytes), and C-reactive protein was 0.33 mg/dL (normal range, 0.5-0.7 mg/dL). All other blood tests had results within normal ranges. The diagnosis was tenosynovitis of both the flexor and extensor mechanisms of the middle digit. Surgical decompression and debridement comprised the treatment of choice.
Under brachial block, a straight incision was performed dorsally, while a Bruner incision was preferred for the palmar area. During dissection, a serous fluid, but no pus, was collected and sent for culture. Copious irrigation with saline and hydrogen peroxide was performed during surgical exploration. Empirical intravenous antibiotic therapy was initiated immediately after surgery, including cefuroxime (750 mg/8 hours), ciprofloxacin (500 mg/12 hours) and clindamycin (600 mg/8 hours).
Fluid culture revealed Enterococcus faecalis in the first 24 hours, while a Gram-positive bacterium grew after 48 hours ( Fig. 1) , which proved to be Erysipelothrix rhusiopathiae. The pathogen was sensitive to penicillin, ampicillin, imipenem, cefuroxime, ceftriaxone, clindamycin and linezolid, while being resistant to vancomycin, teicoplanin, trimethoprim-sulfamethoxazole and tetracycline. The patient continued antibiotic therapy for 2 weeks, followed by 2 weeks of oral antibiotics after being discharged from hospital.
Within the 3 months' follow-up, the inflammation markers were within the normal range, and the patient regained mobility in her digit after an intensive physiotherapy programme (Figs. 2  and 3 ). No signs of recurrence of the disease or of osteomyelitis were detected during follow-up.
Discussion
Erysipelothrix rhusiopathiae was first isolated in 1876 by Koch [1] in a mouse. Not until 1884 did Rosenbach establish it as a human pathogen. It is considered to be a Gram-positive, capsulated saprophyte, with worldwide spread and affecting mostly domestic and wild animals. Erysipelothrix [2] is referred to as an occupational bacteria because its contact with infected animals or their waste causes a variety of clinical syndromes. Sheep, chickens, rodents, shellfish, turkeys and ducks are usual hosts, but domestic swine is the dominant reservoir for the microorganism. It is not only professional workers [3] , such as fishermen, farmers or butchers, who are considered to be at high risk when in close contact with infected animals. Infection can also be accidental [4] , the result of its ability to remain viable in water and animal products, such as ham, or in fish for a long period without forming spores [5] . Human-to-human infection has not been reported.
Erysipeloid is the most common form of infection in humans. It is a mild, cutaneous infection, lasting between 2 and 4 weeks and usually self-limiting. Lesions are confined to fingers and hands, which are being swollen and painful, with spreading at the periphery and decolourization of the central area [6] . Systemic effects are rare, although lymphadenopathy and lymphangiitis are detected in one third of patients [7] . Adjacent arthritis may occur. The diffuse cutaneous form is even rarer, combined with systemic symptoms such as fever, severe headache and even polyarthritis. Recurrence is more often compared to erysipeloid. The most severe form of infection, though the rarest, due to Erysipelothrix is septicaemia, which is almost always related to endocarditis. The aortic valve [8] is mostly affected, with 35% of patients requiring replacement. Mortality is up to 40%, regardless of antibiotic treatment. Risk factors for bactaeremia include diabetes, immunosuppression, alcoholism [9] or renal failure as well as infancy.
Although rarely mentioned in the orthopaedic literature, reports from the last decade show that Erysipelothrix 
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rhusiopathiae is considered to be a causative bacteria for reactive arthritis [10] , osteomyelitis [10] , prosthetic infection [11] and spondylitis [12] . It has also caused septic arthritis after arthroscopic reconstruction of an anterior cruciate ligament [13] . Therefore, tenosynovitis is a rare form of erysipeloid.
Although it is a known occupational pathogen, its infections are often misdiagnosed. In cases of erysipeloid, biopsy samples should be taken of the entire thickness of the dermis, as the bacterium lies in the deeper layers of the skin. When sepsis or endocarditis is diagnosed, a standard blood culture should be performed. Specimens must be put in an infusion broth of 1% glucose at room temperature until reaching the laboratory. Identification should be based on Gram stain, morphology, motility, and hemolytic and biochemical properties, especially production of H 2 S [2] . Generally Erysipelothrix should not be confused with Actinomyces, Lactobacillus, Streptococcus, Listeria monocytogenes or Enterococcus spp.
Penicillin, cephalosporins, fluoroquinolones and lincosamides are the main antibiotic categories used for treatment against infections due to Erysipelothrix. The bacterium is highly resistant to aminoglycosides [2] , vancomycin, sulfonamides, streptomycin and trimethoprim-sulfamethoxazole. Resistance to vancomycin is endogenous as a result of the vanC gene. Susceptibility varies amongst chloramphenicol, tetracyclines and erythromycin. Penicillin G [14] is considered the drug of choice, in doses varying from 12 × 10 6 to 20 × 10 6 U/day. Duration of treatment period depends on whether or not the infection is systemic. In cases of bactaeremia or endocarditis, 4 to 6 weeks of continuous antibiotic therapy is considered an effective treatment period. In complicated cases [15] or in cases of immediate recurrence of the disease, antibiotics can be administrated for up to 16 weeks. Orthopaedic surgeons should be aware of infections due to Erysipelothrix rhusiopathiae, bearing in mind the close correlation between certain professions and animals, domestic or wild. Systemic or not, such infections must be identified immediately in order to prevent severe complications such as endocarditis. Prophylactic measures can reduce occupational exposure and minimize the possible transmission of the pathogen to humans.
